Funding for this research was provided by:
University of Gothenburg
Received: 7 January 2021
Accepted: 13 March 2021
First Online: 22 March 2021
: The Regional Ethical Review Board of the University of Gothenburg approved the study which conformed with the Helsinki Declaration of 1964, as revised in 2013, concerning human and animal rights. All patients have consented to being reported in NDR, while no individual consent is required to be included in this study according to Swedish law.
: All named authors take responsibility for the integrity of the work as a whole and have given their approval for this version to be published.
: Professor Eliasson reports personal fees (expert panels, lectures) from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Mundipharma, Navamedic, NovoNordisk, RLS Global, grants and personal fees from Sanofi, all outside the submitted work. Naveed Sattar has received honoraria from Merck, GSK, MSD, and Novo Nordisk. Moa Lugner, Mervete Miftaraj, Jan Ekelund, Stefan Franzén and Ann-Marie Svensson declare that they have no competing interests.